(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...
Stats | |
---|---|
आज की मात्रा | 25 709 |
औसत मात्रा | 64 070 |
बाजार मूल्य | 16.81B |
EPS | $0.490 ( Q1 | 2024-03-31 ) |
अगली कमाई की तारीख | ( $0 ) 2024-08-07 |
Last Dividend | $0.247 ( 2023-05-18 ) |
Next Dividend | $0 ( N/A ) |
P/E |
37.30 (Sector) 0 (Industry) 0 |
ATR14 | $0.0210 (0.28%) |
मात्रा सहसंबंध
Fresenius SE & Co. KGaA सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Fresenius SE & Co. KGaA सहसंबंध - मुद्रा/वस्त्र
Fresenius SE & Co. KGaA वित्तीय
Annual | 2023 |
राजस्व: | $22.30B |
सकल लाभ: | $5.06B (22.68 %) |
EPS: | $-1.050 |
FY | 2023 |
राजस्व: | $22.30B |
सकल लाभ: | $5.06B (22.68 %) |
EPS: | $-1.050 |
FY | 2022 |
राजस्व: | $40.84B |
सकल लाभ: | $10.73B (26.26 %) |
EPS: | $3.77 |
FY | 2021 |
राजस्व: | $37.52B |
सकल लाभ: | $10.31B (27.48 %) |
EPS: | $0.815 |
Financial Reports:
No articles found.
Fresenius SE & Co. KGaA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.247 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.119 | 2013-05-15 |
Last Dividend | $0.247 | 2023-05-18 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-30 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $2.15 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.7 | -- |
Div. Sustainability Score | 6.26 | |
Div.Growth Potential Score | 1.036 | |
Div. Directional Score | 3.65 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
18 May 2023 | $0.247 | 13 May 2023 | 19 May 2023 | 30 May 2023 |
16 May 2022 | $0.242 | 30 Nov -0001 | 30 Nov -0001 | 21 Jun 2022 |
24 May 2021 | $0.267 | 19 May 2021 | 25 May 2021 | 03 Jun 2021 |
31 Aug 2020 | $0.238 | 10 Jul 2020 | 01 Sep 2020 | 10 Sep 2020 |
20 May 2019 | $0.225 | 08 Apr 2019 | 21 May 2019 | 30 May 2019 |
21 May 2018 | $0.230 | 30 Nov -0001 | 22 May 2018 | 01 Jun 2018 |
15 May 2017 | $0.164 | 29 Jun 2017 | 17 May 2017 | 24 May 2017 |
11 May 2016 | $0.155 | 30 Nov -0001 | 13 May 2016 | 23 May 2016 |
18 May 2015 | $0.123 | 30 Nov -0001 | 20 May 2015 | 29 May 2015 |
14 May 2014 | $0.143 | 30 Nov -0001 | 16 May 2014 | 27 May 2014 |
15 May 2013 | $0.119 | 30 Nov -0001 | 17 May 2013 | 28 May 2013 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TTNDF | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% | |
ENLAY | Ex Dividend Knight | 2023-07-24 | Semi-Annually | 0 | 0.00% | |
PNGAY | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
CHBH | Ex Dividend Knight | 2023-10-12 | Quarterly | 0 | 0.00% | |
LFGP | Ex Dividend Junior | 2023-08-17 | Quarterly | 0 | 0.00% | |
AGLXY | Ex Dividend Junior | 2023-08-23 | Annually | 0 | 0.00% | |
WYGPY | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
GTPS | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
SKLTY | Ex Dividend Knight | 2023-09-05 | Annually | 0 | 0.00% | |
COIHY | Ex Dividend Knight | 2023-08-31 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0243 | 1.500 | -0.486 | -0.729 | [0 - 0.5] |
returnOnAssetsTTM | -0.0149 | 1.200 | -0.498 | -0.598 | [0 - 0.3] |
returnOnEquityTTM | -0.0337 | 1.500 | -1.486 | -2.23 | [0.1 - 1] |
payoutRatioTTM | -1.778 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.354 | 0.800 | 8.23 | 6.59 | [1 - 3] |
quickRatioTTM | 0.603 | 0.800 | -1.161 | -0.929 | [0.8 - 2.5] |
cashRatioTTM | 0.122 | 1.500 | -0.435 | -0.653 | [0.2 - 2] |
debtRatioTTM | 0.287 | -1.500 | 5.21 | -7.82 | [0 - 0.6] |
interestCoverageTTM | 3.11 | 1.000 | 9.96 | 9.96 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.60 | 2.00 | 7.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.58 | 2.00 | 7.21 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.654 | -1.500 | 7.38 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.231 | 1.000 | 9.48 | 9.48 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0599 | 1.000 | -0.803 | -0.803 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.337 | 1.000 | 9.24 | 9.24 | [0.2 - 2] |
assetTurnoverTTM | 0.616 | 0.800 | 9.23 | 7.38 | [0.5 - 2] |
Total Score | 6.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.92 | 1.000 | -0.699 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0337 | 2.50 | -0.955 | -2.23 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.58 | 2.00 | 8.14 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.60 | 2.00 | 7.47 | 10.00 | [0 - 30] |
payoutRatioTTM | -1.778 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -0.0128 | 1.500 | -3.42 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.157 | 1.000 | 8.57 | 0 | [0.1 - 0.5] |
Total Score | 1.036 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं